RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Judith E. Adams et al.|Cancer Epidemiology Biomarkers & Prevention|2017Cited by 6
Age as a prognostic factor in small cell lung cancer:a pooled analysis of randomized clinical trials from the Manchester lung cancer group (MLCG) and theUK medical research council clinical trials unit (MRC CTU)Paul Wheatley‐Price, Fiona Blackhall, Elham Sabri et al.|Research Explorer (The University of Manchester)|2013Cited by 0
Data from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0
Supplementary Table 1 from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0
Supplementary Table 1 from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0